MARKET WIRE NEWS

Zai Lab Limited (ZLAB) Q1 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-05-11 08:55:31 ET

Zai Lab Limited (ZLAB)

Q1 2025 Earnings Conference Call

May 08, 2025, 08:00 AM ET

Company Participants

Christine Chiou - Senior Vice President, Investor Relations

Samantha Du - Founder, Chairperson and Chief Executive Officer

Josh Smiley - President and Chief Operating Officer

Rafael Amado - President, Head of Global Research and Development

Yajing Chen - Chief Financial Officer

Jonathan Wang - Chief Business Officer

Conference Call Participants

Michael Yee - Jefferies

Louise Chen - Scotiabank

Yen-Der Li - Leerink Partners

Li Watsek - Cantor

Yigal Nochomovitz - Citi

Anupam Rama - JPMorgan

Jack Lin - Morgan Stanley

Rebecca Liang - Bernstein

Linhai Zhao - Goldman Sachs

Presentation

Operator

Hello, ladies and gentlemen, thank you for standing by, and welcome to Zai Lab's First Quarter 2025 Financial Results Conference Call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, today's call is being recorded.

It is now my pleasure to turn the floor over to Christine Chiou, Senior Vice President of Investor Relations. Please go ahead.

Christine Chiou

Thank you, operator. Hello, and welcome, everyone. Today's earnings call will be led by Dr. Samantha Du, Zai Lab's Founder, CEO and Chairperson. She will be joined by Josh Smiley, President and Chief Operating Officer; Dr. Rafael Amado, President and Head of Global Research and Development; and Dr. Yajing Chen, Chief Financial Officer. Jonathan Wang, our Chief Business Officer, will also be available to answer questions during the Q&A portion of the call.

As a reminder, during today's call, we will be making certain forward-looking statements based on our current expectations. These statements are subject to numerous risks and uncertainties that may cause actual results to differ materially from what we expect due to a variety of factors, including those discussed in our SEC filings. We will also refer to adjusted loss from operations, which is a non-GAAP financial measure. Please refer to our earnings release furnished with the SEC on May 8, 2025, for additional information on this non-GAAP financial measure.

At this time, it is my pleasure to turn the call over to Dr. Samantha Du.

Samantha Du

Thanks, Christine. Good morning, and good evening, everyone. Thank you for joining us today.

We entered 2025 with a conviction that this will be a pivotal year for Zai Lab, a year where strong execution, disciplined growth and the scientific innovation would begin to shape our long-term trajectory....

Read the full article on Seeking Alpha

For further details see:

Zai Lab Limited (ZLAB) Q1 2025 Earnings Call Transcript
Zai Lab Limited

NASDAQ: ZLAB

ZLAB Trading

-1.63% G/L:

$18.365 Last:

202,921 Volume:

$18.85 Open:

mwn-ir Ad 300

ZLAB Latest News

ZLAB Stock Data

$2,174,273,322
105,108,310
0.9%
39
N/A
Biotechnology & Life Sciences
Healthcare
CN
Shanghai

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App